LOGIN
Ultrasound-Guided Triamcinolone Acetonide Hydrodissection for Carpal Tunnel Syndrome
October 2021
Ultrasound-Guided Triamcinolone Acetonide Hydrodissection for Carpal Tunnel Syndrome
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Ultrasound-Guided Triamcinolone Acetonide Hydrodissection for Carpal Tunnel Syndrome: A Randomized Controlled Trial.
Front Med (Lausanne) . 2021 Sep 13;8:742724.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Sixty-four patients with carpal tunnel syndrome were randomized to receive a single ultrasound-guided corticosteroid hydrodissection (n=32) or a corticosteroid perineural injection (n=32). The primary outcome measure was the symptom severity subscale on the Boston Carpal Tunnel Questionnaire (BCTQ). Secondary outcomes of interest included the functional status subscale of BCTQ, distal motor latenc...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.